Digital Health

News

Daiichi Sankyo has licensed European rights to GAIA's digital therapeutic for people with high cholesterol, currently in phase 3 testing.

Digital

As reported in January this year, the United States Centers for Medicare & Medicaid Services (CMS) rolled out $10 billion in

News

For patients and GPs, accessing NHS services can feel like a "maze of dead ends and detours," according to a new poll.

News

Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by buying Eucalyptus Health.

News

Volunteers with schizophrenia, bipolar, and depression will take part in an NHS study that will use genetic and health data to find new therapies.

Patients

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.